AC

Alexandra Cantley

Partner at Polaris Partners

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $300,000.00

  • Max Investment:

    $2,000,000.00

  • Target Investment:

    $500,000.00

Skills

High Throughput Screening
Organic synthesis
NMR
Mass Spectrometry
chemical biology
HPLC
Environmental microbiology
Analytical Chemistry
Chemical Biology
Organic Synthesis
Western Blotting

Education

  • Doctor of Philosophy (PhD)

    Harvard University

    (2011 - 2016)

  • Bachelor of Arts (B.A.)

    New York University

    (2005 - 2009)

Investments

EpiBiologics

Series A

Total Funding: $96M

Auron Therapeutics

Series A

Total Funding: $48M

TRex Bio

Series A

Total Funding: $26M

Work Experience

Polaris Partners

2019

  • Partner

    2021

  • Principal

    2019

Inzen Therapeutics

2017 - 2019

  • Scientist

    2017 - 2019

Vertex Pharmaceuticals

2016 - 2017

  • Vertex Fellow

    2016 - 2017

Harvard University

2011 - 2016

  • Graduate Student

    2011 - 2016

    Clardy Lab Discovery, isolation and synthesis of natural products that mediate symbiotic interactions between microorganisms.

Columbia University

2009 - 2011

  • Research technician

    2009 - 2011

    Stockwell Lab High throughput screening, cancer research